NO20073256L - Vaksiner mot meningococcus - Google Patents
Vaksiner mot meningococcusInfo
- Publication number
- NO20073256L NO20073256L NO20073256A NO20073256A NO20073256L NO 20073256 L NO20073256 L NO 20073256L NO 20073256 A NO20073256 A NO 20073256A NO 20073256 A NO20073256 A NO 20073256A NO 20073256 L NO20073256 L NO 20073256L
- Authority
- NO
- Norway
- Prior art keywords
- fragment
- variant
- vaccines against
- against meningococcus
- polypeptide
- Prior art date
Links
- 229960005486 vaccine Drugs 0.000 title abstract 3
- 239000012634 fragment Substances 0.000 abstract 3
- 229920001184 polypeptide Polymers 0.000 abstract 3
- 102000004196 processed proteins & peptides Human genes 0.000 abstract 3
- 108090000765 processed proteins & peptides Proteins 0.000 abstract 3
- 230000004927 fusion Effects 0.000 abstract 2
- 241000588650 Neisseria meningitidis Species 0.000 abstract 1
- 125000003275 alpha amino acid group Chemical group 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
- C07K14/22—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Neisseriaceae (F)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/42—Proteins; Polypeptides; Degradation products thereof; Derivatives thereof, e.g. albumin, gelatin or zein
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Organic Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Gastroenterology & Hepatology (AREA)
- Epidemiology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Communicable Diseases (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Oncology (AREA)
- Inorganic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Immunology (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Abstract
Det er beskrevet ulike polypeptider, eller en variant eller fragment av det, eller en fusjon av disse, som er nyttige i en vaksine. Polypeptidet kan være et polypeptid omfattende aminosyre-sekvensen valgt fra en av SEQ ID Nos 2, 4, 6, 8, 10, 12, 14, 16, 18, 20, 22, 24, 26, 28, 30, 32, 34, 36, 38, 40, 42, 44, 46, 48, 50, 52, 54, 56, 58, 60, 62, 64, 66, 68; eller et fragment eller variant av det, eller en fusjon av et slikt fragment eller variant, og er nyttig i en vaksine mot Neisseria meningitidis.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| PCT/GB2004/005441 WO2005060995A2 (en) | 2003-12-23 | 2004-12-23 | Identification of antigenically important neisseria antigens by screening insertional mutant libraries with antiserum |
| PCT/GB2005/005113 WO2006067518A2 (en) | 2004-12-23 | 2005-12-23 | Vaccines against neisseria meningitidis |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| NO20073256L true NO20073256L (no) | 2007-09-17 |
Family
ID=36282716
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO20073256A NO20073256L (no) | 2004-12-23 | 2007-06-25 | Vaksiner mot meningococcus |
Country Status (10)
| Country | Link |
|---|---|
| EP (1) | EP1848457A2 (no) |
| JP (1) | JP2008525008A (no) |
| KR (1) | KR20070094762A (no) |
| CN (2) | CN101115502A (no) |
| AU (1) | AU2005317835A1 (no) |
| CA (1) | CA2592156A1 (no) |
| MX (1) | MX2007007886A (no) |
| NO (1) | NO20073256L (no) |
| RU (1) | RU2007127921A (no) |
| WO (1) | WO2006067518A2 (no) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR20080090447A (ko) * | 2005-12-23 | 2008-10-08 | 임페리얼 이노베이션스 리미티드 | 수막구균 백신 및 그의 용도 |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB9814902D0 (en) * | 1998-07-10 | 1998-09-09 | Univ Nottingham | Screening of neisserial vaccine candidates against pathogenic neisseria |
-
2005
- 2005-12-23 AU AU2005317835A patent/AU2005317835A1/en not_active Abandoned
- 2005-12-23 MX MX2007007886A patent/MX2007007886A/es unknown
- 2005-12-23 CN CNA2005800479621A patent/CN101115502A/zh active Pending
- 2005-12-23 RU RU2007127921/13A patent/RU2007127921A/ru not_active Application Discontinuation
- 2005-12-23 WO PCT/GB2005/005113 patent/WO2006067518A2/en not_active Ceased
- 2005-12-23 CA CA002592156A patent/CA2592156A1/en not_active Abandoned
- 2005-12-23 EP EP05823115A patent/EP1848457A2/en not_active Withdrawn
- 2005-12-23 KR KR1020077015481A patent/KR20070094762A/ko not_active Withdrawn
- 2005-12-23 JP JP2007547670A patent/JP2008525008A/ja active Pending
-
2006
- 2006-12-21 CN CNA2006800516894A patent/CN101370514A/zh active Pending
-
2007
- 2007-06-25 NO NO20073256A patent/NO20073256L/no not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| AU2005317835A1 (en) | 2006-06-29 |
| WO2006067518A2 (en) | 2006-06-29 |
| KR20070094762A (ko) | 2007-09-21 |
| MX2007007886A (es) | 2008-01-16 |
| EP1848457A2 (en) | 2007-10-31 |
| JP2008525008A (ja) | 2008-07-17 |
| CA2592156A1 (en) | 2006-06-29 |
| RU2007127921A (ru) | 2009-01-27 |
| CN101115502A (zh) | 2008-01-30 |
| CN101370514A (zh) | 2009-02-18 |
| WO2006067518A3 (en) | 2006-11-23 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO20063026L (no) | Antistoffer | |
| DK1194560T3 (da) | Antigene Neisseria-peptider | |
| GB2439474A (en) | LI-Key/Antigenic epitope hybrid peptide vaccines | |
| DK1093517T3 (da) | Neisseria-meningitidis-antigener og præparater | |
| NO20050008L (no) | Neisserial vaksinesammensetninger omfattende en kombinasjon av antigener | |
| EP2289545A3 (en) | Supplemented OMV vaccine against meningococcus | |
| DK2071028T3 (da) | HLA-DR-bindende antigenpeptid afledt af WT1 | |
| ATE476508T1 (de) | Neisseriale antigene | |
| ATE468127T1 (de) | Ii-key/antigene epitop-hybrid-peptid-vakzine | |
| UA107330C2 (uk) | Туберкульозний білок rv3616c та його застосування | |
| WO2009025117A1 (ja) | Cdca1ペプチド及びこれを含む薬剤 | |
| DE602004025943D1 (de) | Mikrosomvakzin | |
| DK1328547T3 (da) | Identifikation og modifikation af immundominante epitoper i polypeptider | |
| ATE551069T1 (de) | Mucin-fusionspolypeptid-vakzine, zusammensetzungen und ihre verwendung | |
| DE60331224D1 (de) | Subtilisin-carlsberg-proteine mit verminderter immunogenität | |
| AU2002319501A1 (en) | Materials and methods relating to improved vaccination strategies | |
| ATE474589T1 (de) | Angiogene peptide und ihre verwendungen | |
| DE602006016133D1 (de) | Verwendung von stefin a als gerüstprotein | |
| DK1214088T3 (da) | Proteiner udtrykt af Mycobacterium tuberculosis og ikke af BCG og anvendelse heraf som diagnostiske reagenser og vacciner | |
| NO20005081D0 (no) | Et polypeptid inneholdende aminosyren fra et N-terminalt kolinbindende protein A-truncat, vaksine avledet derfra og anvendelser derav | |
| NO20082810L (no) | Vaksine, og anvendelse av samme | |
| WO2006067518A3 (en) | Vaccines against neisseria meningitidis | |
| NZ597291A (en) | Peptides that mimic non-human cross-reactive protective epitopes of the group b meningococcal capsular polysaccharide | |
| DK1913020T3 (da) | Immunogene konstrukter | |
| NO20083576L (no) | Peptider av regulatoriske eller hjelpeproteiner av HIV, samt sammensetninger og anvendelser derav |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FC2A | Withdrawal, rejection or dismissal of laid open patent application |